(Q73812437)

English

The correlation of serial prostate specific antigen measurements with clinical outcome after external beam radiation therapy of patients for prostate carcinoma

scientific article published on 01 May 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10820353%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

The correlation of serial prostate specific antigen measurements with clinical outcome after external beam radiation therapy of patients for prostate carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10820353%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

prostate carcinoma

1 reference

based on heuristic

inferred from title

author name string

F A Vicini

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10820353%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

L L Kestin

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10820353%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

A A Martinez

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10820353%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

0 references

publication date

1 May 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10820353%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10820353%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

88

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10820353%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10820353%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

2305-2318

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10820353%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

The relationship between biochemical failure and time to nadir in patients treated with external beam therapy for T1-T3 prostate carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000515%2988%3A10%3C2305%3A%3AAID-CNCR15%3E3.0.CO%3B2-3

21 January 2018

Prostate specific antigen nadir achieved by men apparently cured of prostate cancer by radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000515%2988%3A10%3C2305%3A%3AAID-CNCR15%3E3.0.CO%3B2-3

21 January 2018

Serum prostate-specific antigen profile following radiotherapy for prostate cancer: implications for patterns of failure and definition of cure

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000515%2988%3A10%3C2305%3A%3AAID-CNCR15%3E3.0.CO%3B2-3

21 January 2018

A method for determining a prostate-specific antigen cure after radiation therapy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000515%2988%3A10%3C2305%3A%3AAID-CNCR15%3E3.0.CO%3B2-3

21 January 2018

Apples and oranges: building a consensus for standardized eligibility criteria and end points in prostate cancer clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000515%2988%3A10%3C2305%3A%3AAID-CNCR15%3E3.0.CO%3B2-3

21 January 2018

Prostate-specific antigen following radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000515%2988%3A10%3C2305%3A%3AAID-CNCR15%3E3.0.CO%3B2-3

21 January 2018

Rate of PSA rise predicts metastatic versus local recurrence after definitive radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000515%2988%3A10%3C2305%3A%3AAID-CNCR15%3E3.0.CO%3B2-3

21 January 2018

Assessment of endpoints for clinical trials for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000515%2988%3A10%3C2305%3A%3AAID-CNCR15%3E3.0.CO%3B2-3

21 January 2018

Time to second prostate-specific antigen failure is a surrogate endpoint for prostate cancer death in a prospective trial of therapy for localized disease

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000515%2988%3A10%3C2305%3A%3AAID-CNCR15%3E3.0.CO%3B2-3

21 January 2018

Defining biochemical cure for prostate carcinoma patients treated with external beam radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000515%2988%3A10%3C2305%3A%3AAID-CNCR15%3E3.0.CO%3B2-3

21 January 2018

The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000515%2988%3A10%3C2305%3A%3AAID-CNCR15%3E3.0.CO%3B2-3

21 January 2018

Changes in biochemical disease-free survival rates as a result of adoption of the consensus conference definition in patients with clinically localized prostate cancer treated with external-beam radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000515%2988%3A10%3C2305%3A%3AAID-CNCR15%3E3.0.CO%3B2-3

21 January 2018

Pion conformal radiation of prostate cancer: results of a randomized study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000515%2988%3A10%3C2305%3A%3AAID-CNCR15%3E3.0.CO%3B2-3

21 January 2018

Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of biochemical control

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000515%2988%3A10%3C2305%3A%3AAID-CNCR15%3E3.0.CO%3B2-3

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000515%2988%3A10%3C2305%3A%3AAID-CNCR15%3E3.0.CO%3B2-3

21 January 2018

Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000515%2988%3A10%3C2305%3A%3AAID-CNCR15%3E3.0.CO%3B2-3

21 January 2018

Radiotherapy for localized prostate carcinoma. The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000515%2988%3A10%3C2305%3A%3AAID-CNCR15%3E3.0.CO%3B2-3

21 January 2018

Prostatic-specific antigen doubling times in patients with prostate cancer: a potentially useful reflection of tumor doubling time

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000515%2988%3A10%3C2305%3A%3AAID-CNCR15%3E3.0.CO%3B2-3

21 January 2018

The correlation between the ASTRO Consensus Panel definition of biochemical failure and clinical outcome for patients with prostate cancer treated with external beam irradiation. American Society of Therapeutic Radiology and Oncology

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000515%2988%3A10%3C2305%3A%3AAID-CNCR15%3E3.0.CO%3B2-3

21 January 2018

Prostate specific antigen after external beam radiotherapy for prostatic cancer: followup.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000515%2988%3A10%3C2305%3A%3AAID-CNCR15%3E3.0.CO%3B2-3

21 January 2018

Prostate-specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000515%2988%3A10%3C2305%3A%3AAID-CNCR15%3E3.0.CO%3B2-3

21 January 2018

Prostate Specific Antigen in the Management of Patients with Localized Adenocarcinoma of the Prostate Treated with Primary Radiation Therapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000515%2988%3A10%3C2305%3A%3AAID-CNCR15%3E3.0.CO%3B2-3

21 January 2018

Prostate-specific antigen and radiation therapy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000515%2988%3A10%3C2305%3A%3AAID-CNCR15%3E3.0.CO%3B2-3

21 January 2018

Residual disease after radical surgery or radiation therapy for prostate cancer. Clinical significance and therapeutic implications

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000515%2988%3A10%3C2305%3A%3AAID-CNCR15%3E3.0.CO%3B2-3

21 January 2018

Kinetics of serum prostate-specific antigen after external beam radiation for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000515%2988%3A10%3C2305%3A%3AAID-CNCR15%3E3.0.CO%3B2-3

21 January 2018

The fall and rise of prostate-specific antigen. Kinetics of serum prostate-specific antigen levels after radiation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000515%2988%3A10%3C2305%3A%3AAID-CNCR15%3E3.0.CO%3B2-3

21 January 2018

The effect of pelvic radiation therapy on serum levels of prostate specific antigen

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000515%2988%3A10%3C2305%3A%3AAID-CNCR15%3E3.0.CO%3B2-3

21 January 2018

The long-term effect on PSA values of incidental prostatic irradiation in patients with pelvic malignancies other than prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000515%2988%3A10%3C2305%3A%3AAID-CNCR15%3E3.0.CO%3B2-3

21 January 2018

Prostate-specific antigen following prostate radiotherapy: how low can you go?

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000515%2988%3A10%3C2305%3A%3AAID-CNCR15%3E3.0.CO%3B2-3

21 January 2018

Identifiers

10.1002/(SICI)1097-0142(20000515)88:10<2305::AID-CNCR15>3.0.CO;2-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10820353%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10820353%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73812437&oldid=1743113790"